CAS 1505515-69-4

Taletrectinib

CAS : 1505515-69-4

Taletrectinib

Degré de pureté : ≥98%

Masse moléculaire : 551.61g/mol

Ref: 54-BUP03569

Taletrectinib

CAS : 1505515-69-4

Taletrectinib (AB-106) is a new-generation selective inhibitor of ROS1/NTRK including ROS1,NTRK1,NTRK2 and NTRK3.

Formule : C₂₉H₃₄FN₅O₅

Degré de pureté : 99.87% - 99.96%

Couleur et forme : Solid

Masse moléculaire : 551.61

Ref: TM-T22318

Taletrectinib Adipate

Produit contrôlé

CAS : 1505515-69-4

Formule : C₂₉H₃₄FN₅O₅

Couleur et forme : Neat

Masse moléculaire : 551.62

Ref: TR-T757780

Taletrectinib

CAS : 1505515-69-4

Taletrectinib is a small molecule that inhibits the activity of serine proteases, including caspase-3 and cathepsin B. Taletrectinib binds to the active site of these enzymes, preventing them from cleaving their substrate proteins. It has been shown to have antitumor activity in cell cultures as well as in mice with tumors. This drug has a terminal half-life of about 6 hours in human plasma. The safety profile of taletrectinib is similar to those of other drugs used for cancer treatment. This drug has been tested in phase 1 clinical trials and demonstrated an escalation dose response effect. In addition, it demonstrated a favorable safety profile with limited toxicity profiles. Taletrectinib targets lesions on zymogens that are not accessible by other drugs such as lorlatinib or ibrutinib.br> br> Taletrectinib is also being developed for the treatment of neuroendocrine

Formule : C₂₉H₃₄FN₅O₅

Degré de pureté : Min. 95%

Masse moléculaire : 551.6 g/mol

Ref: 3D-FKC51569